AROW vs BLW

AROW's Piotroski F-Score of 3/9 indicates weak financial health, signaling potential distress in operational efficiency and capital structure. The absence of an Altman Z-Score raises concern about bankruptcy risk, especially given the lack of available debt and liquidity metrics. Despite strong profitability (27.76% margin) and explosive earnings growth (216.5% YoY), the stock trades at a premium to its Graham Number ($39.57) and intrinsic value ($78.17), suggesting overvaluation relative to conservative valuation models. The technical trend is bearish, and insider activity is neutral, with no recent trades. Analyst consensus is a hold, reflecting cautious sentiment.

The Advanced Deterministic Scorecard reveals a Piotroski F-Score of 5/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite a high dividend yield of 9.86%, the payout ratio is alarmingly high at 97.73%, threatening sustainability. Profitability metrics are strong on paper with a 91.48% operating margin and 81.91% profit margin, but these are offset by weak liquidity (Current Ratio: 0.07) and negative revenue growth. The stock trades below its Graham Number of $20.91 and intrinsic value estimate of $41.0, suggesting potential undervaluation, but structural risks and poor technical trend (0/100) undermine this advantage.